Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...

The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition ...

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.

A Feature on M&A, VC investment licensing and partnerships focusing on novel targets in autoimmune diseases. The global ...

I’m a dietitian and meal delivery expert who’s tried nearly every service on the market. I tried Epicured to find out if ...

Dr Liz O’Riordan, a breast cancer surgeon and three-time cancer patient, shares the surprising things which raise the risk of ...

Any time you're experiencing painful pooping or the inability to have a bowel movement, it's worth talking to your doctor.

Analysts have recently evaluated AnaptysBio and provided 12-month price targets. The average target is $36.17, accompanied by ...

Teva Pharma Industries Ltd ADR (NYSE: TEVA) is the world's largest generic drug maker, with over 500 generic and biosimilar treatments in its broad portfolio. The medical sector giant also has a line ...